Fred Alger Management, LLC
- SEC CIK
- 0000003520
- Latest filing
- Aug 14, 2026
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by Fred Alger Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,671−100.0% | Sold out | Holders |
| Q1 2026 | 1,671 | $220.1K | <0.1% | −314−15.8% | Reduced | Holders |
| Q4 2025 | 1,985 | $281.5K | <0.1% | −137−6.5% | Reduced | Holders |
| Q3 2025 | 2,122 | $297.9K | <0.1% | +113+5.6% | Added | Holders |
| Q2 2025 | 2,009 | $252.5K | <0.1% | −265−11.7% | Reduced | Holders |
| Q1 2025 | 2,274 | $251.5K | <0.1% | +2,274 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −7,339−100.0% | Sold out | Holders |
| Q4 2023 | 7,339 | $967.0K | <0.1% | −82,599−91.8% | Reduced | Holders |
| Q3 2023 | 89,938 | $10.1M | 0.1% | +89,938 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −176−100.0% | Sold out | Holders |
| Q1 2023 | 176 | $17.8K | <0.1% | −206,521−99.9% | Reduced | Holders |
| Q4 2022 | 206,697 | $24.7M | 0.1% | +206,473+92,175.4% | Added | Holders |
| Q3 2022 | 224 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 224 | $22.0K | <0.1% | +224 | New | Holders |